Featured Products

Latest News

Mar

13

BioChain Responds to Epigenomics’ unilateral termination of license contract

March 12, 2019 Newark, CA BioChain, a US-based company, said today Epigenomics AG of Germany seriously violated the terms of an ongoing licensing contract by publicly announcing on March 6, […]

See All News

We are ISO 9001 & 13485 Registered

Custom Sample Collection & Services

Product Release

BioChain launched CancerSeqPlus: NGS-characterized FFPE Tumor Samples. BioChain has leveraged NGS technologies to provide our customers with annotated reports of copy number variations (CNVs), single-nucleotide polymorphisms (SNPs), and insertions and deletion (indels) in clinically identified formalin fixed paraffin embedded (FFPE) tumor tissues.

See All Products

Who We Are

For over 20 yrs BioChain had been committed to empowering researcher with high quality biospecimens, tools for sample preparation and analysis, and bio-assays to accelerate the development and commercialization of diagnostics, therapeutics and medicine.

<
>
Back to Top
x